NAPHCON FORTE Drug Patent Profile
✉ Email this page to a colleague
When do Naphcon Forte patents expire, and when can generic versions of Naphcon Forte launch?
Naphcon Forte is a drug marketed by Alcon and is included in one NDA.
The generic ingredient in NAPHCON FORTE is naphazoline hydrochloride. There are eight drug master file entries for this compound. Additional details are available on the naphazoline hydrochloride profile page.
Summary for NAPHCON FORTE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 91 |
Patent Applications: | 2,152 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NAPHCON FORTE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for NAPHCON FORTE
US Patents and Regulatory Information for NAPHCON FORTE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon | NAPHCON FORTE | naphazoline hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 080229-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |